ATTD 2026 conference is occurring March 11-14 in Barcelona, Spain, focusing on advanced diabetes technologies including AI-powered solutions.6
Digital Twin AI models create virtual patient representations using CGM, lifestyle, and biomarkers for personalized treatment optimization, glycemic control, and complication reduction, featured in an ADA webinar on Feb 27, 2026.1
Trinity Biotech is attending ATTD 2026 to advance CGM+ partnerships; recent data supports a pivotal 2026 trial meeting modern CGM accuracy standards, aligning with AI-native diabetes analytics.3
Glooko highlights ATTD 2026's emphasis on AI-driven glucose prediction and smart insulin delivery to improve patient outcomes.4
No direct sessions on digital twins found in results, but AI and precision tech discussions position them toward routine diabetes integration.134
Sources:
1. https://professionaleducation.diabetes.org/Listing/The-Role-of-Digital-Twin-AI-Models-in-Diabetes-Care-and-Remission-24018
3. https://www.stocktitan.net/news/TRIB/trinity-biotech-senior-executives-to-attend-attd-2026-to-advance-j6ew7zhw77dg.html